Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer

Am J Surg. 2015 May;209(5):890-5. doi: 10.1016/j.amjsurg.2015.01.011. Epub 2015 Feb 24.

Abstract

Background: Lymphedema is a feared complication of many patients following axillary lymph node dissection for breast cancer. Axillary reverse lymphatic mapping (ARM) was adopted to decrease the incidence of lymphedema.

Methods: A retrospective review was conducted on 139 patients with breast cancer who had greater than 10 lymph nodes removed. A survey was sent to patients to identify those with lymphedema.

Results: One hundred nine women were contacted via mail survey to determine the presence of lymphedema. Of the 46 surveys returned, the incidence of lymphedema was 39%. Twenty-seven percent of the ARM group identified themselves as having lymphedema compared with 50% in non-ARM group. Eighteen percent of women in the ARM group needed an arm sleeve for treatment compared with 45.8% in the non-ARM group.

Conclusions: The incidence of perceived lymphedema and the need for arm compression sleeve devices were lower in the ARM cohort. ARM should be adopted to decrease patient perception of lymphedema.

Keywords: Axillary dissection; Breast cancer; Lymphedema; Managing axilla; Reverse lymphatic mapping.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Axilla
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / secondary
  • Breast Neoplasms / surgery*
  • Coloring Agents
  • Female
  • Humans
  • Incidence
  • Lymph Node Excision / adverse effects*
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphedema / diagnosis
  • Lymphedema / epidemiology*
  • Lymphedema / etiology
  • Middle Aged
  • Retrospective Studies
  • Rosaniline Dyes*
  • United States / epidemiology

Substances

  • Coloring Agents
  • Rosaniline Dyes
  • iso-sulfan blue